Op-Ed
We’re part of a planning group for a covid-19 commission. Here’s why we need one.
The unprecedented development and rollout of coronavirus vaccines is enabling the United States, and a growing number of other countries, to emerge from the worst national and global crisis since 1945. Although the pandemic continues to rage across other parts of the world, it is not too soon to begin a systematic, comprehensive process to learn from both the failures and successes in responding to the outbreak.
That is why the three of us have been part of a planning group for a national covid-19 commission that would undertake a dispassionate study of the pandemic’s course. Such a commission would also examine the vulnerabilities and decisions that affected the pandemic’s health and economic impacts.
The planning group includes epidemiologists, biologists, clinicians, ethicists, and experts in health policy and economics. It was organized, with the support of four foundations, by Johns Hopkins University and the Miller Center at the University of Virginia.
Read the full article.
Duke-Margolis Affiliated Authors
Mark McClellan, MD, PhD
Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty